Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Gross Profit: Breakdown by Business Segment

Breakdown by Business Segment (CNY)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Nuclear Medicines

3.76B 3.93B 4.13B 4.17B 4.02B

Gross Profit

2.7B 2.82B 2.89B 2.92B 2.82B

Medical Laboratory Services

          

Other Businesses

- - 816M 1.31B 1.6B

Gross Profit

- - 84.56M 139M 141M

Independent Clinical Medical and Laboratory Services and Other Businesses (Excluding Radiation Therapy Equipments and Related Services)

338M 754M - - -

Gross Profit

136M 273M - - -

Independent Clinical Medical and Laboratory Services and Other Businesses

- - - - -

Gross Profit

- - - - -

Medical Consumables

          

Radioactive Source Products

555M 618M 638M 746M 836M

Gross Profit

232M 283M 276M 319M 420M

Medical Testing, Analyzing, and Diagnostic Equipment

          

Nuclear Medical Equipment and Related Services

404M 740M 941M 1.23B 602M

Gross Profit

127M 144M 167M 223M 156M

Healthcare Referral Services

          

Irradiation

144M 165M 179M 200M 191M

Gross Profit

73.75M 85.06M 91.43M 102M 107M

Elimination of Inter-Segment

-52.36M -56.49M -71.1M -79.67M -62.82M

Gross Profit

-23.36M -92.83M -30.34M -19.69M -22.43M

Geographical Revenue Distribution History

Geographical breakdown of sales (CNY)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

People's Republic of China (PRC)

5.14B 6.15B 6.63B 7.57B 7.19B

Total Assets

10.47B 11.69B 13.19B 14.77B 15.72B

Interest Expense

-34.04M -32.72M -34.83M -47.2M -64.05M

Income Tax Expense

130M 166M 146M 166M 340M

D&A

191M 213M 255M 235M 255M

CAPEX

-428M -534M -898M -1.03B -567M

Gross Profit

3.24B 3.51B 3.48B 3.68B 3.62B

Net Income

336M 392M 371M 407M 327M

EBT

803M 921M 922M 1.05B 1B

Operating Income

778M 913M 942M 1.09B 1.06B